Evaluation of real-time PCR assay to detect Schistosoma mansoni infections in a low endemic setting

Carregando...
Imagem de Miniatura
Citações na Scopus
34
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
BIOMED CENTRAL LTD
Citação
BMC INFECTIOUS DISEASES, v.14, article ID 558, 10p, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Schistosomiasis constitutes a major public health problem, and 200 million people are estimated to be infected with schistosomiasis worldwide. In Brazil, schistosomiasis has been reported in 19 states, showing areas of high and medium endemicity and a wide range of areas of low endemicity (ALE). Barra Mansa in Rio de Janeiro state has an estimated prevalence of 1%. ALE represent a new challenge for the helminth control because about 75% of infected individuals are asymptomatic and infections occur with a low parasite load (<100 eggs per gram of feces), causing a decrease in sensitivity of stool parasitological techniques, which are a reference for the laboratory diagnosis of this helminth. The objective of this study was to evaluate the performance of a TaqMan quantitative polymerase chain reaction (qPCR) technique in serum and feces DNA samples using the techniques of Kato-Katz (KK), Hoffman, Pons and Janer (HH) as references, during an epidemiological survey using fecal samples and sera from randomized residents from an ALE. Methods: A cross-sectional study conducted from April to December 2011 using a probabilistic sampling that collected 572 fecal and serum samples. The laboratory diagnostic techniques used were: KK, HH and qPCR ( feces and serum). Results: We obtained the following results using the different diagnostic techniques: KK and HH, 0.9% (n = 5); qPCR-feces, 9.6% (n = 55); and qPCR-serum, 1.4% (n = 8). The qPCR-feces presented the highest positivity, whereas the techniques of HH and KK were the least sensitive to detect infections (0.8%). Compared to HH and KK, qPCR-feces showed a statistically significant difference in positivity (p < 0.05), although with poor agreement. Conclusion: The positivity rate presented by the qPCR approach was far higher than that obtained by parasitological techniques. The lack of adequate surveillance in ALE of schistosomiasis indicates a high possibility of these areas being actually of medium and high endemicity. This study presents a control perspective, pointing to the possibility of using combined laboratory tools in the diagnosis of schistosomiasis in ALE.
Palavras-chave
Schistosomiasis mansoni, TaqMan (R) Real-Time PCR system, Laboratory diagnosis, Low endemicity areas, Brazil/epidemiology
Referências
  1. [Anonymous], 2008, SINANNET07052008
  2. Bergquist NR, 2002, TRENDS PARASITOL, V18, P309, DOI 10.1016/S1471-4922(02)02301-2
  3. Brasil. Ministerio da Saude, 1976, CONS DES SOC
  4. Brasil. Ministerio da Saude. Secretaria de Vigilancia a Saude: Sistema de Informacao do Programa de Controle da Esquistossomose, 2012, SIST INF PROGR CONTR
  5. Carneiro TR, 2012, REV SOC BRAS MED TRO, V45, P510, DOI 10.1590/S0037-86822012000400019
  6. Cavalcanti MG, 2013, TRENDS PARASITOL, V29, P75, DOI 10.1016/j.pt.2012.11.003
  7. Chitsulo L, 2000, ACTA TROP, V77, P41, DOI 10.1016/S0001-706X(00)00122-4
  8. CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
  9. Cnops L, 2012, TROP MED INT HEALTH, V17, P1208, DOI 10.1111/j.1365-3156.2012.03060.x
  10. de Janeiro R, 2009, SECRETARIA ESTADO SA
  11. de Noya BA, 2006, MEM I OSWALDO CRUZ, V101, P29, DOI 10.1590/S0074-02762006000900006
  12. Doenhoff MJ, 2004, TRENDS PARASITOL, V20, P35, DOI 10.1016/j.pt.2003.10.019
  13. Ebrahim A, 1997, AM J TROP MED HYG, V57, P706
  14. Engels D, 1996, AM J TROP MED HYG, V54, P319
  15. Enk MJ, 2008, ACTA TROP, V108, P222, DOI 10.1016/j.actatropica.2008.09.016
  16. Enk MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038947
  17. Espírito-Santo Maria Cristina Carvalho do, 2012, Rev Inst Med Trop Sao Paulo, V54, P245
  18. Espirito-Santo MCC, 2011, 47 CONGR SOC BRAS ME, V85, P41
  19. Espirito-Santo MCC, 2012, 18 INT C TROP MED MA, VII, P662
  20. Espirito-Santo MCC, 2014, EXP PARASITOL, V143, P83, DOI 10.1016/j.exppara.2014.05.013
  21. Gomes ALD, 2006, MEM I OSWALDO CRUZ, V101, P133, DOI 10.1590/S0074-02762006000900021
  22. Gomes LI, 2009, MEM I OSWALDO CRUZ, V104, P1194, DOI 10.1590/S0074-02762009000800021
  23. HAMBURGER J, 1991, MOL BIOCHEM PARASIT, V44, P73, DOI 10.1016/0166-6851(91)90222-R
  24. Kato K, 1954, JAPAN J PARASITOL, V3, P35
  25. Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397
  26. Kirkwood BR, 2003, ESSENTIAL MED STAT
  27. Oliveira LMA, 2010, DIAGN MICR INFEC DIS, V68, P416, DOI 10.1016/j.diagmicrobio.2010.07.016
  28. Pontes LA, 2003, AM J TROP MED HYG, V68, P652
  29. Pontes LA, 2002, AM J TROP MED HYG, V66, P157
  30. Pordeus LC, 2008, EPIDEMIOL SERV SAUDE, V17, P163
  31. RUIZTIBEN E, 1979, AM J TROP MED HYG, V28, P230
  32. SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875
  33. SIMPSON AJG, 1984, EUR J BIOCHEM, V139, P41, DOI 10.1111/j.1432-1033.1984.tb07973.x
  34. Sorgho H, 2005, ACTA TROP, V93, P169, DOI 10.1016/j.actatropica.2004.10.006
  35. SPOTILA LD, 1991, MOL BIOCHEM PARASIT, V48, P117, DOI 10.1016/0166-6851(91)90172-3
  36. TEESDALE CH, 1985, T ROY SOC TROP MED H, V79, P369, DOI 10.1016/0035-9203(85)90384-0
  37. Teles HMS, 2001, THESIS U ESTADUAL CA
  38. ten Hove RJ, 2008, T ROY SOC TROP MED H, V102, P179, DOI 10.1016/j.trstmh.2007.10.011
  39. VANKEULEN H, 1985, MOL BIOCHEM PARASIT, V15, P215, DOI 10.1016/0166-6851(85)90121-5
  40. WHO, 2000, REP INF CONS SCHIST
  41. Wichmann D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000422
  42. Wichmann D, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-55
  43. Zhang YY, 2009, ACTA TROP, V112, P16, DOI 10.1016/j.actatropica.2009.05.020
  44. Zhou L, 2011, ACTA TROP, V120, P88, DOI 10.1016/j.actatropica.2011.06.006